Objective: Clinical trials are vital in the context of ovarian cancer and may offer further treatment options during disease recurrence, yet enrollment remains low. Understanding patient and family member experiences with identifying trials can inform engagement and education efforts. Methods: Interviews were conducted with 33 patients who had experience with clinical trial conversations and 39 nominated family members. Thematic analysis examined experiences and generated findings for clinical practice. Results: Trial conversations with providers at diagnosis were uncommon and often overwhelming. Most participants delayed engagement until later in the disease course. With hindsight, though, some wished they considered trials earlier. Diffic...
AbstractBackgroundClinical trials are critical to scientifically evaluate promising new therapies in...
PurposePatients with advanced cancer and oncologists deliberate about early-phase (EP) trials as the...
Participation in cancer clinical trials (CCTs) is an effective means of reducing cancer disparities ...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
PurposeDiscussions between oncologists and advanced cancer patients (ACPs) may touch on the complex ...
Abstract Background Ovarian cancer is the deadliest gynecologic malignancy and the fifth leading cau...
Introduction: Prospective clinical trials are essential to translate new therapy concepts or rather ...
Background: Despite several initiatives by research groups, regulatory authorities, and scientific a...
Many clinical trials recruit fewer participants than the original recruitment target and so interest...
Purpose: Clinical trial enrollment is low among adolescents and young adults (AYAs) with cancer and ...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Clinical trials are essential for the advancement of cancer treatments; however, partici...
UNLABELLED: PURPOSE; Evaluation of the communication and informed consent process in phase I clinica...
Randomized controlled trials are accepted to be the research design of choice to evaluate the effect...
Objectives: To explore why cancer patients do not want or seek information about their condition bey...
AbstractBackgroundClinical trials are critical to scientifically evaluate promising new therapies in...
PurposePatients with advanced cancer and oncologists deliberate about early-phase (EP) trials as the...
Participation in cancer clinical trials (CCTs) is an effective means of reducing cancer disparities ...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
PurposeDiscussions between oncologists and advanced cancer patients (ACPs) may touch on the complex ...
Abstract Background Ovarian cancer is the deadliest gynecologic malignancy and the fifth leading cau...
Introduction: Prospective clinical trials are essential to translate new therapy concepts or rather ...
Background: Despite several initiatives by research groups, regulatory authorities, and scientific a...
Many clinical trials recruit fewer participants than the original recruitment target and so interest...
Purpose: Clinical trial enrollment is low among adolescents and young adults (AYAs) with cancer and ...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Clinical trials are essential for the advancement of cancer treatments; however, partici...
UNLABELLED: PURPOSE; Evaluation of the communication and informed consent process in phase I clinica...
Randomized controlled trials are accepted to be the research design of choice to evaluate the effect...
Objectives: To explore why cancer patients do not want or seek information about their condition bey...
AbstractBackgroundClinical trials are critical to scientifically evaluate promising new therapies in...
PurposePatients with advanced cancer and oncologists deliberate about early-phase (EP) trials as the...
Participation in cancer clinical trials (CCTs) is an effective means of reducing cancer disparities ...